Agent successfully extracted a comprehensive overview of J&J's business model, divisions, and market positioning from the homepage alone. The site was moderately navigable for discovery but lacked depth on pricing, product specifics, and competitive details—typical limitations of a corporate brand homepage designed for stakeholders rather than product researchers.

• ›All three tool calls fetched the same homepage URL (jnj.com/) typed from memory rather than discovered via site navigation. The site did not surface internal links to deeper product, pricing, or competitive information, requiring the agent to rely entirely on homepage content.
• ›Homepage content was sufficient to answer 'what they do' and 'who it's for' with reasonable clarity (two divisions, B2B customer types, mission statement), but the agent correctly identified that pricing information was deliberately absent—expected in pharma/medtech but also a genuine gap for the stated task.
• ›The agent synthesized competitive differentiation from homepage claims about 'dual-domain expertise,' 'pinpoint precision,' and 'patient-centered innovation,' but these were J&J's own self-reported positioning rather than third-party or comparative analysis. The site offered no independent validation.
• ›The agent acknowledged key limitations transparently: no specific competitor comparisons, no business model transparency (revenue splits), and no product-level clinical detail. This reflects the site's design as aspirational/brand-focused rather than informational.
• ›The agent's final answer was grounded entirely in a single, repeatedly-fetched landing page. No navigation to investor relations, product directories, press releases, or subsidiary pages occurred, indicating either the homepage was comprehensive enough or internal site structure was not discoverable through standard link-following.